BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23639828)

  • 1. Reductive activation of mitomycins A and C by vitamin C.
    Paz MM
    Bioorg Chem; 2013 Jun; 48():1-7. PubMed ID: 23639828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reductive activation of mitomycin C by thiols: kinetics, mechanism, and biological implications.
    Paz MM
    Chem Res Toxicol; 2009 Oct; 22(10):1663-8. PubMed ID: 19791750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocatalytic quinone methide formation from mitomycin c.
    Peterson DM; Fisher J
    Biochemistry; 1986 Jul; 25(14):4077-84. PubMed ID: 3091069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reductive activation of mitomycin C.
    Hoey BM; Butler J; Swallow AJ
    Biochemistry; 1988 Apr; 27(7):2608-14. PubMed ID: 3132971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reductive activation of mitomycin A by thiols.
    Paz MM; Tomasz M
    Org Lett; 2001 Sep; 3(18):2789-92. PubMed ID: 11529757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reductive activation of potential antitumor mitosene compounds.
    Maliepaard M; de Mol NJ; Janssen LH; Hoogvliet JC; van der Neut W; Verboom W; Reinhoudt DN
    J Med Chem; 1993 Jul; 36(15):2091-7. PubMed ID: 8340912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reductive alkylation of DNA by mitomycin A, a mitomycin with high redox potential.
    McGuinness BF; Lipman R; Goldstein J; Nakanishi K; Tomasz M
    Biochemistry; 1991 Jul; 30(26):6444-53. PubMed ID: 1905153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitomycin dimers: polyfunctional cross-linkers of DNA.
    Paz MM; Kumar GS; Glover M; Waring MJ; Tomasz M
    J Med Chem; 2004 Jun; 47(12):3308-19. PubMed ID: 15163210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox cycles of caffeic acid, alpha-tocopherol, and ascorbate: implications for protection of low-density lipoproteins against oxidation.
    Laranjinha J; Cadenas E
    IUBMB Life; 1999 Jul; 48(1):57-65. PubMed ID: 10791916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of the cytotoxic activity of mitomycin C by oxygen and ascorbic acid in Chinese hamster ovary cells and a repair-deficient mutant.
    Marshall RS; Rauth AM
    Cancer Res; 1986 Jun; 46(6):2709-13. PubMed ID: 3084075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs.
    Celli CM; Tran N; Knox R; Jaiswal AK
    Biochem Pharmacol; 2006 Jul; 72(3):366-76. PubMed ID: 16765324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reaction of reductively activated mitomycin C with aqueous bicarbonate: Isolation and characterization of an oxazolidinone derivative of cis-1-hydroxy-2,7-diaminomitosene.
    Paz MM
    Bioorg Med Chem Lett; 2010 Jan; 20(1):31-4. PubMed ID: 19954979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1.
    Keyes SR; Fracasso PM; Heimbrook DC; Rockwell S; Sligar SG; Sartorelli AC
    Cancer Res; 1984 Dec; 44(12 Pt 1):5638-43. PubMed ID: 6437671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential toxicity of mitomycin C and porfiromycin to aerobic and hypoxic Chinese hamster ovary cells overexpressing human NADPH:cytochrome c (P-450) reductase.
    Belcourt MF; Hodnick WF; Rockwell S; Sartorelli AC
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):456-60. PubMed ID: 8552660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of hypoxic and aerobic cytotoxicity of mitomycin C in Chinese hamster V79 cells.
    Krishna MC; DeGraff W; Tamura S; Gonzalez FJ; Samuni A; Russo A; Mitchell JB
    Cancer Res; 1991 Dec; 51(24):6622-8. PubMed ID: 1660344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of quinone redox cycling by ascorbate induces a caspase-3 independent cell death in human leukaemia cells. An in vitro comparative study.
    Verrax J; Delvaux M; Beghein N; Taper H; Gallez B; Buc Calderon P
    Free Radic Res; 2005 Jun; 39(6):649-57. PubMed ID: 16036343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new mechanism of action for the anticancer drug mitomycin C: mechanism-based inhibition of thioredoxin reductase.
    Paz MM; Zhang X; Lu J; Holmgren A
    Chem Res Toxicol; 2012 Jul; 25(7):1502-11. PubMed ID: 22694104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitosene-DNA adducts. Characterization of two major DNA monoadducts formed by 1,10-bis(acetoxy)-7-methoxymitosene upon reductive activation.
    Maliepaard M; de Mol NJ; Tomasz M; Gargiulo D; Janssen LH; van Duynhoven JP; van Velzen EJ; Verboom W; Reinhoudt DN
    Biochemistry; 1997 Jul; 36(30):9211-20. PubMed ID: 9230054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo.
    Rauth AM; Mohindra JK; Tannock IF
    Cancer Res; 1983 Sep; 43(9):4154-8. PubMed ID: 6409398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic potential of monoalkylation products between mitomycins and DNA: studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines.
    Kim SY; Rockwell S
    Oncol Res; 1995; 7(5):39-47. PubMed ID: 8534933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.